跳至主要内容
临床试验/ISRCTN12925323
ISRCTN12925323进行中(未招募)Unknown

Discovering the molecular signatures of cancer PROMotion to INform prevENTion (PROMINENT): Smoking Cessation Study

niversity of Manchester0 个研究点目标入组 200 人开始时间: 2024年9月2日最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1.1. Self-reported current cigarette smoker
  • 1.2. Carbon Monoxide (CO) reading >=5 ppb
  • 1.3. Intends to quit smoking / undertake a smoking quit attempt within 3 months
  • 1.4. No prior history of cancer
  • 1.5. Able to provide informed consent
  • 2. Lung Health Check attendees
  • 2.1. Aged >=55 years
  • 2.2. PLCOM2012 score >=1.51% (or eligible for screening if alternative risk model is used)
  • 3. MFT-CURE attendees
  • 3.1. Aged >=40 years

排除标准

  • 1.1. Never or former smoker (has not smoked within the last 2 weeks)
  • 1.2. Carbon Monoxide (CO) reading <5 ppb
  • 1.3. Prior history of cancer
  • 2. Lung Health Check attendees
  • 2.1. Aged <55 years
  • 2.2. Decline or unable to undertake LDCT screening
  • 3. MFT-CURE attendees
  • 3.1. Aged <40 years

研究者

发起方
niversity of Manchester

相似试验

已完成
不适用
Molecular Fingerprinting in CancerC34C61C50C67C56C00-C14C18C22C25Malignant neoplasm of bronchus and lungMalignant neoplasm of prostateMalignant neoplasm of breastMalignant neoplasm of bladderMalignant neoplasm of ovaryMalignant neoplasms of lip, oral cavity and pharynxMalignant neoplasm of colonMalignant neoplasm of liver and intrahepatic bile ductsMalignant neoplasm of pancreas
DRKS00013217udwig-Maximilians Universität München, Fakultät für Physik,3,479
招募中
不适用
Molecular Fingerprinting in Cancer DetectioC34C61C50C67C00-C14C18C22C25C95J44.1N40K74.6K85K63D14.3K50.1J18.9D27N60.2Malignant neoplasm of bronchus and lungMalignant neoplasm of prostateMalignant neoplasm of breastMalignant neoplasm of bladderMalignant neoplasms of lip, oral cavity and pharynxMalignant neoplasm of colonMalignant neoplasm of liver and intrahepatic bile ductsMalignant neoplasm of pancreasLeukaemia of unspecified cell typeChronic obstructive pulmonary disease with acute exacerbation, unspecifiedHyperplasia of prostateOther and unspecified cirrhosis of liverOther diseases of intestineBronchus and lungCrohn disease of large intestinePneumonia, unspecifiedBenign neoplasm of ovaryFibroadenosis of breastAcute pancreatitis
DRKS00019844udwig-Maximilians-Universität München (LMU)38,000
进行中(未招募)
Unknown
Enabling genomic testing in cancer of unknown primaryCancer of unknown primaryCancer
ISRCTN42910771The Christie NHS Foundation Trust100
撤回
不适用
Molecular Markers in Cancers and Precancers (MOCA)Precancerous LesionHealthyCancer
NCT05257707Centre Hospitalier Universitaire de Besancon300
招募中
不适用
The Cancer Molecular Screening and Therapeutics (MoST) Program-ScreeningCancer - Any cancerCancer
ACTRN12616000908437niversity of Sydney7,628
PROMINENT Smoking Cessation Study | 临床试验